Qisda Corporation · TWSE:2352
Qisda — Q4 2019 Earnings Presentation
9 slides from Qisda's earnings presentation, Mar 27, 2020
Slide 1: Qisda Corporation Investor Conference: 2019 Q4 Results
Qisda Corporation Investor Conference : 2019 Q4 Results Mar 27, 2020
Slide 2: Safe Harbor Notice
Safe Harbor Notice We have made forward-looking statements in the presentation. Our forward-looking statements contain information regarding, among other things, our financial conditions, future expansion plans and business strategies. We have based these forward-looking statements on our current ex
Slide 3: 2019 Q4 Financial Results and Business Summary
2019 Q4 Financial Results and Business Summary
Slide 4: Statement of Comprehensive Income (Consolidated) - Q4
Statement of Comprehensive Income (Consolidated) Amount : NT$ Million 2019 Q4 2018 Q4 Net Sales 45,862 100.0% 42,387 100.0% Cost of Goods Sold (39,990) (37,302) Gross Margin 5,872 12.8% 5,086 12.0% Operating Expenses (4,527) -9.9% (3,822) -9.0% Operating Income 1,346 2.9% 1,263 3.0% Non-operating In
Slide 5: Statement of Comprehensive Income (Consolidated) - Full Year
Statement of Comprehensive Income (Consolidated) Amount : NT$ Million 2019 2018 Net Sales 169,754 100.0% 155,783 100.0% Cost of Goods Sold (146,704) (136,540) Gross Margin 23,050 13.6% 19,243 12.4% Operating Expenses (16,822) -9.9% (14,667) -9.4% Operating Income 6,228 3.7% 4,576 2.9% Non-operating
Slide 6: Balance Sheet Highlights (Consolidated)
Balance Sheet Highlights (Consolidated) Amount : NT$ Million 2019.12.31 2018.12.31 Cash & Equivalent 10,781 8% 9,619 8% Accounts Receivable 31,300 23% 28,110 23% Inventory 27,891 21% 25,063 21% L-T Investments 17,778 13% 19,383 16% Total Assets 136,026 100% 119,807 100% Fin. Debt * 36,994 27% 33,400
Slide 7: Key Financial Ratios (Consolidated)
Key Financial Ratios (Consolidated) 2019.12.31 2018.12.31 (a) AR Turnover (Days) 79 78 Inventory Turnover (Days) 66 60 AP Turnover (Days) 77 76 Cash Conversion Cycle (Days) 68 62 ROE (annualized) 10.0% 11.5% Current ratio 119% 108% Fin. Debit (b)/ Total Assets 27% 28% (a) AR included AR factoring (b
Slide 8: Revenue Breakdown by Product Line
Revenue Breakdown by Product Line 100% 6% 6% 6% 7% 10% 14% 6% 6% 7% 7% 7% 8% 7% 7% 8% 7% 80% 7% BBS 13% 6% 13% 14% 13% 14% 12% Medical 10% 10% 8% 60% 9% Others 8% 8% ICT-Others 40% PRJ 59% LCD 57% 58% 57% 54% 53% 20% 0% Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 * BBS : BenQ business solution * Medical : i
Slide 9: Qisda Value-Up Solutions
Ojisda Value-Up Solutions Qisda